Myocardial dysfunction & atrial disorders
Refractory heart failure no longer equates to therapeutic impasse. In this discussion, Emanuele Barbato and Alexandre Mebazaa explore how this challenging condition has become a catalyst for innovation and collaboration. Highlighting the importance of early and accurate diagnosis, they advocate for a truly transdisciplinary model of care, combining pharmacological advances with device-based interventions.
From cardiac resynchronisation therapy to the integration of multi-specialist teams, this conversation sheds light on how a transdisciplinary and patient-centred strategy can redefine outcomes in advanced heart failure.
